F Dx Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$31.71 - $43.0 $176,783 - $239,725	-5,575 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$29.88 - $37.04 $166,581 - $206,498	5,575 New	5,575 $206,000
Q4 2021 Feb 01, 2022	SELL	$25.61 - $35.1 $192,254 - $263,495	-7,507 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$33.54 - $40.55 $29,146 - $35,237	-869 Reduced 10.37%	7,507 $252,000
Q2 2021 Aug 05, 2021	BUY	$34.54 - $47.25 $22,727 - $31,090	658 Added 8.53%	8,376 $334,000
Q1 2021 Apr 14, 2021	BUY	$42.51 - $63.78 $313,341 - $470,122	7,371 Added 2124.21%	7,718 $347,000
Q1 2021 Apr 13, 2021	SELL	$42.51 - $63.78 $290,640 - $436,063	-6,837 Reduced 95.17%	347 $15,000
Q4 2020 Feb 08, 2021	BUY	$45.3 - $60.27 $46,387 - $61,716	1,024 Added 16.62%	7,184 $406,000
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $32,503 - $43,120	685 Added 12.51%	6,160 $292,000
Q2 2020 Jul 22, 2020	SELL	$46.85 - $61.05 $11,806 - $15,384	-252 Reduced 4.4%	5,475 $323,000
Q1 2020 May 22, 2020	BUY	$41.6 - $63.4 $238,243 - $363,091	5,727 New	5,727 $271,000
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $267,196 - $407,218	-6,423 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $15,454 - $18,732	287 Added 4.68%	6,423 $388,000
Q3 2019 Nov 07, 2019	BUY	$59.06 - $72.15 $20,730 - $25,324	351 Added 6.07%	6,136 $368,000
Q2 2019 Jul 19, 2019	BUY	$62.09 - $86.14 $78,792 - $109,311	1,269 Added 28.1%	5,785 $372,000
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $53,607 - $82,225	-1,013 Reduced 18.32%	4,516 $367,000
Q4 2018 Apr 29, 2019	SELL	$43.37 - $59.54 $125,165 - $171,832	-2,886 Reduced 34.3%	5,529 $299,000
Q4 2018 Feb 07, 2019	BUY	$43.37 - $59.54 $95,847 - $131,583	2,210 Added 35.62%	8,415 $455,000
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $5,102 - $6,390	-119 Reduced 1.88%	6,205 $320,000
Q2 2018 Aug 08, 2018	BUY	$40.53 - $50.7 $30,802 - $38,532	760 Added 13.66%	6,324 $264,000
Q1 2018 May 02, 2018	SELL	$44.08 - $55.05 $6,083 - $7,596	-138 Reduced 2.42%	5,564 $245,000
Q4 2017 Feb 09, 2018	BUY	$50.3 - $64.39 $13,178 - $16,870	262 Added 4.82%	5,702 $287,000
Q3 2017 Nov 03, 2017	BUY	$45.56 - $59.57 $7,654 - $10,007	168 Added 3.19%	5,440 $276,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,272	5,272 $268,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account